Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 7/20 | 0.52 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 0.45 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.43 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8775926 | 0.82 | NR3C2 (0.44) | KCNA5LMNAHPGDHTTSMN1; SMN2 | |
| SCHEMBL8775839 | 0.80 | KCNA5 (0.48) | KCNA5LMNAHPGDHTTSMN1; SMN2 | |
| SCHEMBL8775748 | 0.78 | ALOX5 (0.63) | ALOX5TRPM8KCNA5HTT | |
| SCHEMBL8776065 | 0.76 | ALOX5 (0.52) | ALOX5TRPM8KCNA5LMNAHPGD | |
| SCHEMBL8775859 | 0.74 | TBXAS1 (0.60) | ALOX5TRPM8KCNA5LMNAHPGD | |
| SCHEMBL8775894 | 0.74 | SLC7A5 (0.55) | KCNA5LMNAHPGDHTTSMN1; SMN2 | |
| SCHEMBL8775759 | 0.74 | TBXAS1 (0.62) | ALOX5KCNA5LMNAHPGDHTT | |
| SCHEMBL8775890 | 0.74 | TBXAS1 (0.62) | ALOX5KCNA5LMNAHPGDHTT | |
| SCHEMBL8775961 | 0.72 | TBXAS1 (0.53) | ALOX5KCNA5LMNAHPGDHTT | |
| SCHEMBL13524545 | 0.72 | ALOX5 (1.00) | ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0807626-A1 | N-HYDROXYUREA DERIVATIVES | Nikken Chemicals Company, Limited (JP) | 1997-11-19 | — | — | EP | disclosed |